Lichenoid type cutaneous hyperpigmentation induced by nebivolol

Creative Commons License

Aslan A. N., Guney M. C., AKÇAY M., KELEŞ T., BOZKURT E.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.45, no.3, pp.268-270, 2017 (ESCI) identifier identifier identifier


Cutaneous hyperpigmentation is a common and well-defined side effect of many drugs, such as nonsteroidal anti-inflammatory drugs, beta-blockers, and tetracyclines, but to the best of our knowledge there is no case of skin discoloration related to nebivolol in the literature. Presently described is lichenoid type cutaneous hyperpigmentation in a 46-year-old female patient. Hyperpigmentation emerged 3 months after initiating use of nebivolol and resolved after cessation of drug use. It was concluded that effect emerged as result of therapeutic doses of nebivolol.